Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

"Sulbactomax" patent from Mexico strengthens Venus Remedies' presence in Latin America

 Venus Remedies Ltd has informed BSE regarding "Sulbactomax" patent from Mexico strengthens Venus Remedies' presence in Latin America"Announcement :The Company, has received yet another patent grant from the IMPI (Instituto Mexicano de la Propiedad Industrial) for one of its researched products Sulbactomax, With this grant Venus Remedies has SULBACTOMAX patent in total 42 countries, including Europe, and the patent for this product is valid till 2024....
24-02-2011
Bigul

Venus Remedies Anti-Cancer drug "GEMCITABINE" gets UK MHRA approval

 Venus Remedies Ltd has informed BSE regarding "Venus Remedies Anti-Cancer drug "GEMCITABINE" gets UK MHRA approval"Announcement:"The Company achieved yet another landmark by receiving the Market Authorization for GEMCITABINE, one of the key products for the treatment of Cancer via decentralized procedure from Medicine and Healthcare Regulatory Agency (MHRA) U.K, The other countries in the list are Poland, Germany, Slovenia and Portugal for which the same feat has been achieved....
02-02-2011
Bigul

Financial Results for Dec 31, 2010

 Venus Remedies Ltd has informed BSE about the Financial Results for the Quarter ended December 31, 2010.
28-01-2011
Bigul

Outcome of Board Meeting

 Venus Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 12, 2011, inter alia, has:1. Approved increase in the borrowing limit upto Rs. 500 crores over and above paid share capital and free reserve of the Company under Section 293 (1) (d) of Companies Act 1956 and also approved the increase in limits inter alia for creation of charge/mortgage etc. over and above paid share capital and...
12-01-2011
Bigul

Venus Remedies to expand innovations basket with Sulbactomax Patent from Russia & Ukraine

 Venus Remedies Ltd has informed BSE regarding "Venus Remedies to expand innovations basket with Sulbactomax Patent from Russia & Ukraine"Press Release:"We are pleased to inform you that the Company has received patent grants for SULBACTOMAX, one of the key research products of company, from Federal service on Intellectual Property, Patents and Trademarks (ROSPATENT), Russia and state Enterprise Ukrainian Institute of Industrial Property...
27-12-2010
Bigul

Outcome of Board Meeting

 Venus Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 18, 2010, inter alia, has approved allotment of 37,137 equity shares of Rs. 10/- each pursuant to request for partly conversion of Foreign Currency Convertible Bonds by FCCB holders, out of US$ 5 million bonds rollover till 2015.
18-12-2010
Bigul

Board Meeting on Dec 18, 2010

 Venus Remedies Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on December 18, 2010, to consider allotment of 37,137 equity shares pursuant to request for partly conversion of Foreign Currency Convertible Bonds by FCCB holders, out 5 million bonds rollover till 2015.
09-12-2010
Bigul

Annual report for Venus Remedies Ltd. for FY-2010
28-04-2010
Close

Let's Open Free Demat Account